​

Chemomab Therapeutics Ownership | Who Owns Chemomab Therapeutics?

OverviewForecastChart

Chemomab Therapeutics Ownership Summary

Chemomab Therapeutics is owned by 4.75% institutional investors, 12.19% insiders, and 83.07% retail investors. Kestra private wealth services is the largest institutional shareholder, holding 0.96% of CMMB shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 9.46% of its assets in Chemomab Therapeutics shares.

CMMB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockChemomab Therapeutics4.75%12.19%83.07%
SectorHealthcare Stocks 246.48%12.12%-158.60%
IndustryBiotech Stocks 384.82%11.76%-296.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Kestra private wealth services77.15K0.96%$91.81K
Stonex group18.62K0.23%$29.81K
Smartharvest portfolios13.03K0.16%$15.51K
Caitong asset management17.000.00%$20.00
Gamma investing---
Rhumbline advisers---
Susquehanna group, llp---
Jane street group---
Virtu financial---
Boothbay fund management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Smartharvest portfolios13.03K0.01%$15.51K
Stonex group18.62K0.00%$29.81K
Kestra private wealth services77.15K0.00%$91.81K
Susquehanna group, llp---
Gamma investing---
Rhumbline advisers---
Jane street group---
Virtu financial---
Boothbay fund management---
Lido advisors---

Top Buyers

HolderShares% AssetsChange
Stonex group18.62K0.00%18.62K
Kestra private wealth services77.15K0.00%15.44K
Smartharvest portfolios13.03K0.01%13.03K
Caitong asset management17.00-9.00
Ubs group---8.00

Top Sellers

HolderShares% AssetsChange
Orbimed advisors---940.99K
Sphera funds management---738.05K
Yelin lapidot management---578.29K
Ikarian capital---213.05K
Rhumbline advisers---39.88K

New Positions

HolderShares% AssetsChangeValue
Stonex group18.62K0.00%18.62K$29.81K

Sold Out

HolderChange
Ubs group-8.00
Sbi securities-111.00
Moser wealth advisors-500.00
Jpmorgan chase-1.18K
Wetzel investment advisors-11.00K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202613-13.33%379,8338.04%424.45%5-50.00%433.33%
Mar 31, 202615-351,560-4-15---
Jun 30, 202514-17.65%4,230,78813.37%-70.20%7-22.22%3-
Mar 31, 2025176.25%3,731,679-10.31%169.98%950.00%3-50.00%
Dec 31, 2024166.67%4,160,723-8.55%176.12%6-40.00%6500.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
HBM Healthcare Investments AG Ord1.01M9.46%784.65K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 27, 2026Cohen Neil Harris-Sell$3.72K
Aug 28, 2026Cohen Neil Harris-Sell$2.80K
May 29, 2026Mor George Adi Chief Executive OfficerSell$10.00K
May 29, 2026Mor George Adi Chief Executive OfficerSell$10.25K
Jan 03, 2023OrbiMed Israel GP Ltd.-Sell$889.70K

Insider Transactions Trends

DateBuySell
2027 Q1--
2026 Q2--
2026 Q1--
2023 Q2--
2023 Q1-4

CMMB Ownership FAQ

Who Owns Chemomab Therapeutics?

Chemomab Therapeutics shareholders are primarily institutional investors at 4.75%, followed by 12.19% insiders and 83.06% retail investors. The average institutional ownership in Chemomab Therapeutics's industry, Biotech Stocks , is 384.82%, which Chemomab Therapeutics falls below.

Who owns the most shares of Chemomab Therapeutics?

Chemomab Therapeutics’s largest shareholders are Kestra private wealth services (77.15K shares, 0.96%), Stonex group (18.62K shares, 0.23%), and Smartharvest portfolios (13.03K shares, 0.16%). Together, they hold 1.36% of Chemomab Therapeutics’s total shares outstanding.

Does Blackrock own Chemomab Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Chemomab Therapeutics.

Who is Chemomab Therapeutics’s biggest shareholder by percentage of total assets invested?

Smartharvest portfolios is Chemomab Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 13.03K Chemomab Therapeutics shares, valued at 15.51K$.

Who is the top mutual fund holder of Chemomab Therapeutics shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of Chemomab Therapeutics shares, with 9.46% of its total shares outstanding invested in 1.01M Chemomab Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools